| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophys J, August 2002, p. 808-818, Vol. 83, No. 2
Department of Bioengineering, University of California, San Diego, La Jolla, California 92093 USA
| |
ABSTRACT |
|---|
|
|
|---|
The development of high-throughput technologies and the resulting large-scale data sets have necessitated a systems approach to the analysis of metabolic networks. One way to approach the issue of complex metabolic function is through the calculation and interpretation of extreme pathways. Extreme pathways are a mathematically defined set of generating vectors that describe the conical steady-state solution space for flux distributions through an entire metabolic network. Herein, the extreme pathways of the well-characterized human red blood cell metabolic network were calculated and interpreted in a biochemical and physiological context. These extreme pathways were divided into groups based on such criteria as their cofactor and by-product production, and carbon inputs including those that 1) convert glucose to pyruvate; 2) interchange pyruvate and lactate; 3) produce 2,3-diphosphoglycerate that binds to hemoglobin; 4) convert inosine to pyruvate; 5) induce a change in the total adenosine pool; and 6) dissipate ATP. Additionally, results from a full kinetic model of red blood cell metabolism were predicted based solely on an interpretation of the extreme pathway structure. The extreme pathways for the red blood cell thus give a concise representation of red blood cell metabolism and a way to interpret its metabolic physiology.
| |
INTRODUCTION |
|---|
|
|
|---|
A constraints-based approach to the
mathematical modeling and in silico study of reconstructed metabolic
networks has been developed (Palsson, 2000
). This approach successively
imposes governing constraints on a biochemical reaction network
including connectivity, thermodynamic irreversibility, and maximum flux capacities to limit the steady-state flux solutions to a closed solution space (Schilling et al., 1999
, 2000
). Markedly, no kinetic parameters are used in defining this space. However, if the kinetic parameters are known the precise location of the steady-state flux
distribution in the solution space can be found using a model that
involves simultaneously solving a system of differential equations.
Such comprehensive kinetic models are available for the human red blood
cell (Mulquiney and Kuchel, 1999
; Lee and Palsson, 1991
; Joshi and
Palsson, 1989
, 1990
), and such a precise solution can be calculated.
Steady-state analysis of stoichiometric networks has been reviewed
recently (Schilling et al., 1999
) and the steady-state solution space
is a convex hull, or cone, where the edges are so-called "extreme
pathways." An algorithm to compute the extreme pathways has been
described (Schilling et al., 2000
) and applied to the genome-scale
metabolic network of Hemophilus influenzae (Schilling and
Palsson, 2000
). The extreme pathways for a genome-scale network are
large and challenging to both compute and interpret (Papin et al.,
2002
). However, the subsequent imposition of gene expression regulation
significantly reduces the number of allowable extreme pathways under a
given condition (Covert et al., 2001b
).
The difficulties associated with the computation and interpretation of large numbers of extreme pathways for real metabolic networks have hampered their detailed biochemical and physiological study. These computational issues arise from both the size and complexity of the metabolic networks. Although these cone-generating vectors correspond to biochemical pathways that represent steady-state flux maps, they have yet to be examined in detail for a biologically realistic metabolic system to determine their characteristics and usefulness in analyzing and interpreting integrated metabolic functions. The human red blood cell provides an attractive case to study the extreme pathways. Its metabolism contains four basic classical pathways: glycolysis, the pentose pathway, adenosine nucleotide metabolism, and the Rapoport-Leubering shunt. Unlike most metabolic networks, the red cell does not need to generate biomass; its main task is to produce the necessary cofactors (ATP, NADPH, and NADH) for maintaining its osmotic balance and electroneutrality and fighting oxidative stresses. The relatively simplistic demands on the red cell network serve to reduce the system's complexity and help make the computation of its extreme pathways manageable. The human red blood cell model accounts for 39 metabolites and 32 internal metabolic reactions, as well as 12 primary exchange and 7 currency exchange fluxes. The extreme pathways of this simple metabolic network can be readily calculated from the stoichiometric matrix. Herein we study these extreme pathways.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
The metabolic network and its stoichiometric matrix
Thirty-nine metabolites are included in the red blood cell
network (Table 1). To calculate the
extreme pathways, those metabolites that can be exchanged with the
system boundary (both as primary exchanges and currency exchanges) are
identified (Schilling et al., 2000
). Primary exchange metabolites are
those that can be thought of as being transported across the cell
membrane and exchanged with the environment (Fig.
1). Currency exchanges are exchanges of
cofactors and metabolites that are produced and used by the metabolic
network for such tasks as running the Na/K Pump (ATP), reducing
met-Hemoglobin (NADH), fighting oxidative stresses to the cell via
glutathione reduction (NADPH), and regulating hemoglobin oxygen
affinity (2,3-DPG). The elemental composition of each metabolite in the
network is given in Table 2 and it is
used to ensure that every reaction in the network is elementally
balanced. The metabolic reactions, excluding transporters, are shown in
Table 3. The full red blood cell
stoichiometric matrix is derived from these reactions and the
corresponding metabolic map is shown in Fig. 1.
|
|
|
|
Extreme pathway calculation and classification
The extreme pathways are calculated based on:
|
|
Extreme pathways can be divided into three main categories: type I,
which are through pathways that utilize primary exchange fluxes as
defined in Table 2; type II, which are futile cycles that only utilize
currency exchange fluxes and degrade charged cofactors such as ATP; and
type III, which are simply reversible reactions with no exchange fluxes
involved (Schilling et al., 1999
). Note that the type I pathways
include traditional pathways with a single substrate in and a single
product out, and the simultaneous production of cofactors.
| |
RESULTS |
|---|
|
|
|---|
Extreme pathway structure of the red blood cell
The computation of the extreme pathways for the red blood cell metabolic network resulted in 36 type I, 3 type II, and 16 type III extreme pathways. The type I and II extreme pathways are of most interest and will be focused on herein. The net reactions (exchanges only) are contained in Table 1 for both type I and II extreme pathways.
The type I and II extreme pathways can be described in detail based on their function and corresponding steady-state flux map. The complete collection of all 39 steady-state flux maps referred to below can be found in Fig. 5.
Glucose to pyruvate (GP)
These pathways show three basic routes from glucose to pyruvate: classic glycolysis (GP1), glycolysis and cyclic pentose phosphate metabolism (PPP) (GP2), and glycolysis and PPP (GP3). GP1 produces the standard two ATP, two NADH, and two pyruvate from one glucose molecule. GP3 enters the PPP (bypassing PGI) where carbon is lost to CO2 but NADPH is produced. The net result is a decrease in the net production of ATP, NADH, and pyruvate per glucose molecule, as compared to GP1, in exchange for the production of the glutathione reducing cofactor NADPH. GP2 takes GP3 a step further and actually cycles through PPP repeatedly, causing an even greater loss of carbon through the decarboxylation reaction of PDGH, but an increase in the production of NADPH in addition to the single ATP, NADH, and pyruvate formed per glucose molecule. Each of these three pathways has a nearly identical twin pathway (GP5, GP6, GP7) that utilizes the 2,3-DPG shunt (DPGM and DPGase) as opposed to the ATP producing reaction catalyzed by PGK. The cell can use the shunt to curb its ATP production. GP4 supplements the glucose substrate with inosine to ultimately produce the cofactors ATP, NADH, and NADPH, as well as pyruvate. However, due to the low transport rate of inosine (Vmax in Table 3), this is a low-flux pathway. GP4 has a mirror image pathway (GP8) in which the 2,3-DPG shunt is utilized instead of PGK.Pyruvate/lactate conversion (PL)
Pathways PL1 and PL2 represent the reversible conversion between pyruvate and lactate that can occur in the cell and ultimately is used to balance the NAD/NADH ratio. Note that in the homeostatic steady state there is no load on NADH and the red blood cell utilizes PL2 to completely balance all NADH produced via any GP pathways utilized.2,3-DPG production (DPG)
The basic routes of four of these pathways (DPG1 and DPG4-6) are identical to those from group I (GP5-8), the only difference being that instead of simply diverting flux through the shunt and back into main glycolysis, 2,3-DPG is siphoned off for use in the regulation of the oxygen affinity of hemoglobin. In addition, DPG2 and DPG3 utilize inosine as the sole substrate, with no uptake of glucose (similar to IP3 and IP4 described below).Inosine to pyruvate (IP)
These pathways (IP1-4) mirror GP1, GP2, GP5, and GP6, respectively, with the only difference being that inosine is used as the sole substrate instead of glucose. Inosine is converted, via adenosine metabolism, into R5P, which enters pentose phosphate metabolism and is eventually converted into pyruvate via glycolysis. Again, these are low-flux pathways due to the low transport rate for inosine.Salvage pathways using adenine (SP)
The salvage pathways (SP1-3) combine adenine with a pentose to alter the adenosine nucleotide pool inventory.Nucleotide incorporation/removal via glucose and adenine (GA)
These pathways (GA1-6) use glucose and adenine to adjust the nucleotide pool size via either the oxidative or non-oxidative branch of the PPP.Nucleotide incorporation/removal via inosine and adenosine (IA)
Similar to the SP group, these pathways (IA1-4) regulate the adenosine pool size through the uptake/secretion of inosine and adenosine.Adenosine to inosine (AI)
These two pathways (AI1-2) simply convert adenosine to inosine for use in nucleotide metabolism.Dissipation of ATP (type II pathways, DIS)
These futile cycles (DIS1-3) serve to dissipate excess ATPMaximal fluxes through the extreme pathways
Maximum flux capacities of the reactions serve to "cap off" the steady-state solution cone forming a closed polytope (Fig. 2 A). Every reaction has an estimated absolute Vmax value of 1 × 106 molecules/s/µm3 set by physico-chemical limitations. However, a few enzymes in the metabolic network will have a lower maximum flux capacity, i.e., low Vmax due to kinetic limitations of the enzyme (Table 3). The enzyme with the lowest Vmax in an extreme pathway serves as the "bottleneck" and determines the maximum possible flux through that extreme pathway. For instance, the low uptake rate of inosine limits the fluxes through all the extreme pathways in which it is utilized.
|
Response to metabolic loads in red blood cell metabolism
There are four main physiologic loads experienced by the red blood
cell, and the extreme pathways can be interpreted in terms of these
metabolic demands.
| 1. | ATP loads are a combination of the Na/K ATPase-driven pump used in osmotic and ion balance as well as general ATP-related cell maintenance. ATP loads are experienced at the normal physiologic steady state as the pump must constantly be run and cellular volume maintained. Such loads are modeled by the conversion of ATP to ADP and Pi. Hence, some combination of extreme pathways that convert ADP to ATP must be utilized, which includes the GPs and the IPs, which is consistent with the nominal steady state in which ~80% of the flux in the system is through glycolysis (GP1 and GP5), ~15% is through the PPP (GP2-4, GP6-8), and the rest is through the adenosine reactions (IP1-4). If ATP is produced by the system in excess, it can be dissipated via one of the type II futile cycle pathways (DIS1-3); |
| 2. | Oxidative loads in the red blood cell are combated via glutathione reduction, which must then be reoxidized by NADPH. There is a basal level of oxidative load on the cell at the physiologic steady state. Oxidative loads are modeled via the oxidation of NADPH to NADP. Because NAPDH can only be produced in the oxidative branch of the PPP, pathways GP2-4 and/or GP6-8 must be utilized; |
| 3. | 2,3-DPG loads are experienced in conditions such as high altitude, where the oxygen affinity of hemoglobin must be altered. However, at the physiologic steady state there is no drain on 2,3-DPG. The only pathways that produce 2,3-DPG which can be drained from the system are DPG1-6 which, while not "turned on" in nominal steady state, will become active under load; |
| 4. | NADH loads are used to convert the unusable form of methylated hemoglobin (met-Hb) into the oxygen-carrying form of hemoglobin. Under normal, steady-state conditions, however, there is no drain on NADH. Hence, all the extreme pathways that result in the production of pyruvate are not technically utilized (GP1-8 and IP1-4). Rather, these pathways function in tandem with PL2 to balance NADH and produce lactate (Fig. 3). Note that such combinations of extreme pathways lie on a "face" of the conical solution space and represent an elementary flux mode (Schuster et al., 2000 |
|
Extreme pathways and the interpretation of physiological responses
The stoichiometry of a metabolic network, and hence the extreme pathway structure of that network, is relatively easy to obtain as compared with acquiring detailed kinetic knowledge about each enzyme in the network. A number of valuable physiological insights can be obtained from network structure and basic reaction capacity limitations, as the following examples demonstrate.
Projection of pathways based on production of key cofactors
The high-dimensional steady-state flux cone as defined by the extreme pathways can be projected onto a 2-D flux space (see Fig. 4 A, inset). A projection of interest, Fig. 4 A, shows ATP and NADPH production by extreme pathways, which can be interpreted by the fluxes through the ATP and NADPH use reactions (Fig. 1).
|
Change in global adenosine inventory in the red blood cell
There are several extreme pathways that lead to a net change in the adenosine inventory (i.e., [A] + [AMP] + [ADP] + [ATP]), including SP1-3, GA1-6, and IA1-5. The flux through these extreme pathways is restricted to between 0.01 and 0.03 mM/h because they are all limited by one or more low effective Vmax reactions, including adenine (ADE) and adenosine (ADO) transport, and the internal deaminase reaction catalyzed by AMPDA (Table 3). The steady-state adenosine inventory in the red blood cell is ~3 mM, and thus the time constant associated with changes in the inventory is (3 mM)/(0.01 mM/h) ~ 300 h ~ 12 days. The slow changes in the adenosine inventory in red blood cells is known and represents a challenge in blood storage (Grimes, 1980Adjustment in 2,3-DPG concentration
All the pathways that drain the pool of 2,3-DPG must go through DPGase whose flux is restricted to ~0.5 mM/h (Werner and Heinrich, 1985SNPs and maximal capacities
The Vmax values of the enzymes serve to "cap off" the steady-state solution cone (Fig. 2). Changes or alterations in these Vmax values can significantly change the shape of the steady-state solution space. If all the extreme pathways are high throughput (i.e., limiting Vmax is large), the solution space is relatively large (Fig. 2 A). However, as shown in Fig. 2 B, if one of the Vmax values is low due to some sort of defect or significant kinetic regulation, the volume of the solution space shrinks significantly, which reduces the number of steady-state solutions and hence the number of homeostatic options available to the cell. Thus, Vmax values can effectively reduce the solution space and eliminate a large number of possible states of the network. Any enzymopathies that reduce this capacity region will result in a pathological phenotype in response to challenges that normal red blood cells would tolerate (Fig. 4 B). Well-defined polymorphisms reduce the ability of the red blood cell to respond to oxidative and energy loads (Nagel, 1988| |
DISCUSSION |
|---|
|
|
|---|
Extreme pathway analysis has been applied to the human red blood cell metabolic network. The resulting extreme pathways were analyzed and classified based on their structure and functional capabilities. The results of this study are 1) the establishment of a complete set of extreme pathways for a biologically meaningful system, 2) the finding that some of the extreme pathways correspond to "classical" biochemical pathways but most do not, and 3) a demonstration that extreme pathways can be used to interpret the steady-state solution space with respect to network capabilities.
Previously, extreme pathway analysis was applied to sample systems
without real biological meaning (Schilling et al., 2000
). Such systems
helped in establishing the algorithm and interpreting the results, but
provided no real biological insight. At the other extreme, the analysis
has been applied to genome-scale metabolic network, resulting in an
immense number of extreme pathways for which a detailed interpretation
is not possible. Only statistical properties of these large sets of
data could be obtained yielding limited insight into cellular
physiology (Papin et al., 2002
). This red blood cell study represents a
situation where the full set of extreme pathways was calculated,
detailed, and used for physiological interpretation. Scaling such
detailed analysis to a genome-scale represents an unmet challenge in
this field.
The systemic extreme pathways of the red blood cell metabolic network were fully enumerated and described (Fig. 5). In contrast to traditional experimental discovery and heuristic definitions of metabolic pathways, extreme pathway analysis provides a unique, mathematically defined way to identify systemically meaningful metabolic pathways that may be unintuitive, but no less informative. Interestingly, "historical" pathways such as glycolysis (GP1 in Fig. 5) and nucleotide salvage pathways (SP1-3 in Fig. 5) are extreme pathways. However, a majority of the extreme pathways are nontraditional multiple input-multiple output pathways such as those in which glucose and inosine are used in tandem to produce pyruvate and hypoxanthine, as well as the cofactors ATP and NADH (GP4 in Fig. 5). Such nontraditional pathways are an example of how extreme pathway analysis can elucidate systemic properties resulting from network interconnectedness and complexity, an essential feature of emerging systems biology.
|
Extreme pathway analysis can also be used to interpret and predict the systemic consequences of maximum capabilities of individual reactions in the network (Fig. 4 A); a priori, a seemingly impossible task for a model based solely on stoichiometric information. In this case, the maximum cofactor production capacity of the red blood cell was conservatively predicted by the extreme pathway structure and the tolerance to elevated metabolic demands defined. The incorporation of basic transport and reaction Vmax values and approximate metabolite concentration data expands the utility of extreme pathway analysis to include estimation of time constants with respect to pathway usage and prediction of the effect of enzyme defects on systemic function (Fig. 4 B).
With the emergence of systems biology comes a need for new methods for
defining and understanding metabolic pathways as they pertain to
network-scale functions. A recent article by Marcotte begs the
question: "Why not abandon the old representation of pathways and
instead work directly with the networks?" (Marcotte, 2001
). Many
different methods for such pathway definitions have been proposed to
understand whole-cell metabolism, including Ouzounis's database
definitions (Ouzounis and Karp, 2000
), Schuster's elementary flux
modes (Schuster et al., 1999
, 2000
), and Schilling's extreme pathways
(Schilling et al., 2000
). Such computational methods are essential for
providing the link between mathematics and biology. Extreme pathways
provide a unique way to define metabolic pathways in the era of systems
biology. The main challenges that currently face extreme pathway
analysis are their computation for genome-scale networks and the
physiological interpretation of the results.
The present study represents the first complete analysis of the extreme
pathway structure of a real metabolic system. Previously, the extreme
pathway algorithm has either been applied to simple example systems for
which the pathways could be interpreted but were not physiologically
relevant, or to a genome-scale model for which the pathways were most
certainly meaningful but were simply too numerous to individually
interpret. The human red blood cell provides an ideal test bed that
combines simplicity with physiologic significance. The results from the
extreme pathway analysis show that network structure and capacity
constraints provide a strong basis for analysis and interpretation of
the physiology of the red blood cell metabolic network. Genome-scale metabolic networks can now be reconstructed from genomic and other data
sources (Covert et al., 2001a
). The use of extreme pathways for the
analysis of such reconstructed networks and their relation to
whole-cell functions will thus become critical in the advancement of
systems biology.
| |
ACKNOWLEDGMENTS |
|---|
The authors thank Iman Famili and Neema Jamshidi for valuable discussions and help with the figures.
This work is funded by the National Science Foundation (Graduate Research Fellowships BES98-14092, MCB98-73384, and BES-0120363) and the National Institutes of Health (Grant GM57089).
| |
FOOTNOTES |
|---|
Address reprint requests to Bernhard O. Palsson, 9500 Gilman Drive, La Jolla, CA 92093. Tel.: 858-534-5668; Fax: 858-822-3120; E-mail: palsson{at}ucsd.edu.
Submitted January 25, 2002, and accepted for publication April 8, 2002.
| |
REFERENCES |
|---|
|
|
|---|
Biophys J, August 2002, p. 808-818, Vol. 83, No. 2
© 2002 by the Biophysical Society 0006-3495/02/08/808/11 $2.00
This article has been cited by other articles:
![]() |
F. J. Planes and J. E. Beasley A critical examination of stoichiometric and path-finding approaches to metabolic pathways Brief Bioinform, September 1, 2008; 9(5): 422 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-S. Miao, P. Song, R. E. Savage, C. Zhong, R.-Y. Yang, D. Kizer, H. Wu, E. Volckova, M. A. Ashwell, J. G. Supko, et al. Identification of the in Vitro Metabolites of 3,4-Dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione (ARQ 501; {beta}-Lapachone) in Whole Blood Drug Metab. Dispos., April 1, 2008; 36(4): 641 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wagner and R. Urbanczik The Geometry of the Flux Cone of a Metabolic Network Biophys. J., December 1, 2005; 89(6): 3837 - 3845. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Thiele, N. D. Price, T. D. Vo, and B. O. Palsson Candidate Metabolic Network States in Human Mitochondria: IMPACT OF DIABETES, ISCHEMIA, AND DIET J. Biol. Chem., March 25, 2005; 280(12): 11683 - 11695. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Famili, R. Mahadevan, and B. O. Palsson k-Cone Analysis: Determining All Candidate Values for Kinetic Parameters on a Network Scale Biophys. J., March 1, 2005; 88(3): 1616 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Price, J. Schellenberger, and B. O. Palsson Uniform Sampling of Steady-State Flux Spaces: Means to Design Experiments and to Interpret Enzymopathies Biophys. J., October 1, 2004; 87(4): 2172 - 2186. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Price, J. L. Reed, J. A. Papin, I. Famili, and B. O. Palsson Analysis of Metabolic Capabilities Using Singular Value Decomposition of Extreme Pathway Matrices Biophys. J., February 1, 2003; 84(2): 794 - 804. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |